Spain extends AstraZeneca dose gap to 16 weeks, beyond EU approved limit

  • 9 months   ago
Spain extends AstraZeneca dose gap to 16 weeks, beyond EU approved limit

Spain is extending the gap between the first and second doses of AstraZeneca's (AZN.L) COVID-19 vaccine to 16 weeks for people aged under 60, the government said on Friday, going beyond the 12-week maximum interval approved by European authorities.

Spain is the first country to diverge from the European Medicines Agency's (EMA) authorisation and promote "off label use", which would not be approved by the regulator and would leave individual nations responsible for any possible side-effects.

Comments